A new study published in the Journal of Periodontology showed that periodontitis severity and total prostate-specific antigen ...

There is a shadow disease that often lurks unnoticed, growing quietly within a man’s body which is hidden behind the mundane routine of daily life, masked by ag ...

A leading doctor has answered several common questions about prostate cancer in an effort to separate facts from fiction. His ...

This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is ...

Dr Thornton stressed that ignoring symptoms and postponing doctor visits are among the worst strategies for dealing with ...

A prominent doctor has tackled several frequently asked questions regarding prostate cancer in a bid to distinguish fact from ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...

Coversure Insurance Brokers has launched a network-wide prostate cancer screening initiative, funding free prostate-specific ...

Investigators compared PSA90 response between new users of apalutamide vs abiraterone for mCSPC using a large US cohort.

PYLCLARI® provides solutions to a wider patient group across Poland where there is high demand and unmet need PARIS, Dec. 23, ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...